Corporate Integrity Agreement (CIAs) are a tool commonly employed by the HHS OIG to resolve healthcare fraud issues. This article explores the issue of whether CIAs really strengthen company compliance programs. This author is not so sure
Corporate Integrity Agreements (CIAs) are arguably the preferred tool used by the federal and state governments since 2001 to resolve healthcare fraud issues. According to the Office of the Inspector General (OIG), CIAs strengthen compliance programs and promote compliance so that future issues can be prevented or identified, reported and corrected. But do they? How can a company have integrity without a strong ethics backbone?
Read Full Article in the July 2016 Issue of Life Science Compliance Update